Christopher Miller

Statistics

Publications

Citations

3.8K

H-Index

Active since

2007

Affiliations

Technische Universität Dresden(Current)

The Ohio State University Wexner Medical Center

National Medical Research Center of Cardiology

Estudios Clínicos Latinoamérica

University of Colorado Denver

Christopher Miller is an author at Technische Universität Dresden specializing in medicine, type 2 diabetes mellitus treatment, and placebo-controlled efficacy assessment.

ORCID

Publications per year

2007–2022

Publications

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

Medicine, Endocrinology, Pharmacology +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

Medicine, Endocrinology, Nephrology +15

Impact of Serum Phosphate in Mechanically Ventilated Patients With Severe Sepsis and Septic Shock

Christopher Miller, Bruce Doepker, Andrew N Springer et al. · Journal of Intensive Care Medicine · 2018 · 56 citations

Veterinary Medicine, Nephrology, Critical Care Pharmacology +12

EARLY INITIATION OF VASOPRESSIN REDUCES ORGAN FAILURE AND MORTALITY IN SEPTIC SHOCK

Alexandria C. Rydz, Jessica L. Elefritz, Megan Conroy et al. · Shock · 2022 · 20 citations

Medicine, Perioperative Medicine, Perioperative Critical Care +15

Plaque‐like Myofibroblastic Tumor of Infancy

Jennie T. Clarke, Loren E. Clarke, Christopher Miller et al. · Pediatric Dermatology · 2007 · 16 citations

Medicine, Dermatology, Pathology +17

1–5 of 5